Alcohol use and clinical manifestations of tuberculosis

References 

1. Anon. Trends in tuberculosis – United States, 2007. MMWR Morbidity and Mortality Weekly Report 57:281–5.
2. Buskin SE, Gale JL, Weiss NS, Nolan CM. Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. American Journal of Public Health 84:1750–6.
3. Centers for Disease Control and Prevention. Appendix SUR I RVCT Form Completion Instructions version 1.20. Last updated on 2003. <http://ftp.cdc.gov/pub/Software/TIMS/Documentation/Apx%20SUR%20I%20RVCT%20Form%20Completion%20Instructions.pdf> [accessed on 5-20-2006].
4. McNutt LA, Wu C, Xue X, Haffner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology 157:940–3.
5. Walker GA. Common statistical methods for clinical research with SAS examples. 2nd ed.. Cary, NC: SAS Institute Inc.; 2002;
6. Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and homelessness in the United States, 1994–2003. JAMA; 293:2762–6.
7. Fleming MF, Krupitsky E, Tsoy M, Zvartau E, Brazhenko N, Jakubowiak W, et al. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. International Journal of Tuberculosis and Lung Disease 10:565–70.
8. Moran A, Harbour DV, Teeter LD, Musser JM, Graviss EA. Is alcohol use associated with cavitary disease in tuberculosis? Alcoholism, Clinical and Experimental Research 31:33–8.
9. Rodrigo T, Cayla JA, Garcia dO, Galdos-Tanquis H, Jansa JM, Miranda P, et al. Characteristics of tuberculosis patients who generate secondary cases. International Journal of Tuberculosis and Lung Disease 1:352–7.
10. Wang CS, Chen HC, Chong IW, Hwang JJ, Huang MS. Predictors for identifying the most infectious pulmonary tuberculosis patient. Journal of the Formosan Medical Association 107:13–20.
11. True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC, et al. Common genetic vulnerability for nicotine and alcohol dependence in men. Archives of General Psychiatry 56:655–61.
12. Altet-Gomez MN, Alcaide J, Godoy P, Romero MA, Hernandez del Rey I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. International Journal of Tuberculosis and Lung Disease 9:430–6.
13. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Archives of Internal Medicine 167:335–42.
14. Leung CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, et al. Smoking and tuberculosis among the elderly in Hong Kong. American Journal of Respiratory and Critical Care Medicine 170:1027–33.
15. Arcavi L, Benowitz NL. Cigarette smoking and infection. Archives of Internal Medicine 164:2206–16.
16. Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proceedings of the American Thoracic Society 2:428–32.
17. Vander Top EA, Wyatt TA, Gentry-Nielsen MJ. Smoke exposure exacerbates an ethanol-induced defect in mucociliary clearance of Streptococcus pneumoniae. Alcohol Clinical and Experimental Research 29:882–7.
18. Vander Top EA, Perry GA, Snitily MU, Gentry-Nielsen MJ. Smoke exposure and ethanol ingestion modulate intrapulmonary polymorphonuclear leukocyte killing, but not recruitment or phagocytosis. Alcohol Clinical and Experimental Research 30:1599–607.
19. Mazzarella G, Bianco A, Perna F, et al. T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. Clinical and Experimental Immunology 132:283–8.
20. Anon. Tuberculosis transmission in a homeless shelter population – New York, 2000–2003. MMWR Morbidity and Mortality Weekly Report 54:149–52.
21. Anon. Public health dispatch: tuberculosis outbreak among homeless persons – King County, Washington, 2002–2003. MMWR Morbidity and Mortality Weekly Report 52:1209–10.
22. Kiwuwa MS, Charles K, Harriet MK. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study. BMC Public Health, 5:122.
23. van der Werf MJ, Chechulin Y, Yegorova OB, Marcinuk T, Stopolyanskiy A, Voloschuk V, et al. Health care seeking behaviour for tuberculosis symptoms in Kiev City, Ukraine. International Journal of Tuberculosis and Lung Disease 10:390–5.
24. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Short-term incarceration for the management of noncompliance with tuberculosis treatment. Chest 112:57–62.
25. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. International Journal of Tuberculosis and Lung Disease 6:780–8.
26. Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, et al. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. International Journal of Tuberculosis and Lung Disease 10:542–9.
27. Diel R, Niemann S. Outcome of tuberculosis treatment in Hamburg: a survey, 1997–2001. International Journal of Tuberculosis and Lung Disease 7:124–31.
28. Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. American Journal of Medicine 102:164–70.
29. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. New England Journal of Medicine 330:1179–84.
30. Anon. Racial disparities in tuberculosis – selected southeastern states, 1991–2002. MMWR Morbidity and Mortality Weekly Report 53:556–9.
31. Stout JE, Ratard R, Southwick KL, Hamilton CD. Epidemiology of human immunodeficiency virus testing among patients with tuberculosis in North Carolina. Southern Medical Journal 95:231–8.
32. Hoyer G, Nilssen O, Brenn T, Schirmer H. The Svalbard study 1988–89: a unique setting for validation of self-reported alcohol consumption. Addiction 90:539–44.